Management of Guillain-Barré syndrome (GBS)
- PMID: 9117079
Management of Guillain-Barré syndrome (GBS)
Abstract
GBS is an acute immune-mediated neuropathy which, in one-third of cases, leads to total paralysis requiring ICU admission for assisted ventilation and management of autonomic cardiovascular instability. The management can be challenging and even with most expert care and modern ICU facilities the mortality remains at 5-8%. This chapter gives an outline of the natural history and pathophysiology of the condition with emphasis on newer concepts. Guidelines are given for the management of patients prior to and during the admission to an ICU by highlighting the potential complications. An up-to-date account is given on the specific immunomodulatory therapies.
Similar articles
-
Guillain-Barré syndrome: recent advances.Hosp Med. 1998 Jan;59(1):55-60. Hosp Med. 1998. PMID: 9798567 Review.
-
High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.Turk J Pediatr. 1996 Jan-Mar;38(1):119-23. Turk J Pediatr. 1996. PMID: 8819632
-
[Therapy of acute polyradiculoneuritis (Guillain-Barré syndrome)].Nervenarzt. 1994 Dec;65(12):807-18. Nervenarzt. 1994. PMID: 7854501 Review. German.
-
[Value of intravenous immunoglobulins. A case of Guillain-Barré syndrome].Rev Neurol (Paris). 1992;148(11):706-8. Rev Neurol (Paris). 1992. PMID: 1303562 French.
-
Management and outcome of severe Guillain-Barré syndrome.QJM. 1995 Apr;88(4):243-50. QJM. 1995. PMID: 7796073
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical